Literature DB >> 25924817

The effects of sulforaphane on the liver and remote organ damage in hepatic ischemia-reperfusion model formed with pringle maneuver in rats.

Abdullah Oguz1, Murat Kapan2, Ibrahim Kaplan3, Ulas Alabalik4, Burak Veli Ulger2, Omer Uslukaya2, Ahmet Turkoglu2, Yilmaz Polat5.   

Abstract

BACKGROUND: The purpose of this study was to investigate the effect of Sulforaphane on ischemia/ reperfusion (IR) injury of the liver and distant organs resulting from liver blood flow arrest.
MATERIALS AND METHODS: Fourty Wistar rats were assigned into four groups, each included 10 rats were used. Group I as only laparatomy, Group II laparatomy and Sulforaphane application, Group III hepatic IR; and Group IV as hepatic IR and Sulforaphane application group. Animals were subjected to liver ischemia for 30 min and then reperfusion is started. 5 mg/kg Sulforaphane was applied via oral lavage 15 minutes before initiating the experimental study. Blood samples were taken from the animals for biochemical analysis at 60th minutes of the experiment in the first and second groups; 30 minutes after beginning reperfusion in the third and forth groups. Simultaneously, liver, lung and kidney tissues were sampled for biochemical and histopathological examinations.
RESULTS: The administration of sulforaphane significantly reduced the serum TOA and liver TOA levels, increased the serum TAC and liver TAC levels and also decreased The OSI and liver OSI levels. In the histopathologic examination, the injury was reduced by the administration of sulforaphane. Administration of sulforaphane did not lead to any significant changes in any parameter including histopathological parameters in both the kidney and the lung.
CONCLUSIONS: Sulforaphane reduced the liver oxidative stress from I/R injury. A histological injury in liver was reduced by sulforaphane administration. However, there were no significant effects of sulforaphane on the remote organ injuries induced by IR.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hepatic ischemia-reperfusion; Kidney; Liver; Lung; Remote organs; Sulforaphane

Mesh:

Substances:

Year:  2015        PMID: 25924817     DOI: 10.1016/j.ijsu.2015.04.049

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  4 in total

1.  Protective effects of sulforaphane and aerobic exercise on acute alcoholic hepatic injury in mice.

Authors:  Juan Wang; Haixin Zhou
Journal:  Saudi J Biol Sci       Date:  2020-07-14       Impact factor: 4.219

2.  Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion.

Authors:  Marijan Kolovrat; Slaven Gojkovic; Ivan Krezic; Dominik Malekinusic; Borna Vrdoljak; Katarina Kasnik Kovac; Tamara Kralj; Domagoj Drmic; Ivan Barisic; Katarina Horvat Pavlov; Andreja Petrovic; Antonija Duzel; Mario Knezevic; Ivan Mirkovic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Hepatol       Date:  2020-05-27

3.  Current potential health benefits of sulforaphane.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2016-10-13       Impact factor: 4.068

4.  Protective Effects of Caffeic Acid Phenethyl Ester on Fluoxetine-Induced Hepatotoxicity: An Experimental Study.

Authors:  Ahmet Yılmaz; Bilal Elbey; Ümit Can Yazgan; Ahmet Dönder; Necmi Arslan; Serkan Arslan; Ulaş Alabalık; Hamza Aslanhan
Journal:  Biomed Res Int       Date:  2016-04-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.